Ovarian cancer and additional women-related diseases are late diagnosed resulting in poor life quality and mortality. Gina Life is developing an early detection test to ovarian cancer and additional diseases, by using Machine Learning and Artificial Intelligence and analyzing vaginal secretions. This test will be performed at home using a smart phone, and will enable women to take control over their health.
We gained knowledge of the US healthcare system, regulation and reimbursement. Most importantly, we are establishing a collaboration with Mayo Clinic which will enable us to expand our clinical activity.
"Participating in the Mayo Clinic accelerator enables Gina Life to expand its activity and knowledge, and generates an opportunity to collaborate with leading experts in our field."
CEO and Co-founder